Medtronic opened higher at $98.00, compared with its previous close of $97.11. In the last trading session, the stock traded between $96.72 and $98.09. It showed a sideways intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Medtronic is now worth
$ 81.14
resulting in a loss of
$ 18.86 (18.86%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 19 Analysts
Buy
52.63%
Hold
47.37%
Sell
0%
Markets Today
Today's Change
+$0.14 (+0.14%)
Day High
$98.09
Day Low
$96.72
Day Open
$98.00
Prev Close
$97.11
Volume
24,83,260
1W Return
0.70%
1M Return
11.63%
3M Return
11.08%
6M Return
22.53%
1Y Return
6.02%
Fundamentals
Market Cap ($ Mn)
1,24,398
PE Ratio
24.46
PB Ratio
2.36
PEG Ratio
3.50
ROE
9.61%
ROCE
8.08%
EPS (TTM)
$1.15
Investment Returns
1 Week
0.70%
1 Month
11.63%
3 Months
11.08%
6 Months
22.53%
9 Months
-3.71%
Financials
Quarterly
All values in $ Mn
8.9K
Apr 25
8.6K
Jul 25
9.0K
Oct 25
9.0K
Jan 26
9.8K
Apr 26
9.8K
Jul 26
Updates
8Oct
Medtronic sets final exchange ratio at 4.5939 for MiniMed split-off
Final exchange ratio set at 4.5939 MiniMed shares per Medtronic ordinary share. Offer capped at 225,361,295 MiniMed shares, extendable by 27,452,053 if oversubscribed. Exchange offer expires on October 9, 2026, with potential proration if oversubscribed.
22 days ago
2Oct
Medtronic secures AMA approval for two new Category I CPT codes
Medtronic received AMA approval for new Category I CPT codes. Codes cover Altaviva for urge urinary incontinence. Codes cover Symplicity Spyral for uncontrolled hypertension. New codes replace existing Category III identifiers. Approval effective from January 2028.
28 days ago
16Sep
Medtronic secures FDA clearance for LigaSure RAS instrument on Hugo system
FDA cleared LigaSure RAS Maryland device for Hugo robotic system in U.S. Instrument seals vessels up to 7 mm in approximately 2 seconds. Technology used in more than 45 million procedures globally. Hugo system currently cleared for urologic procedures in U.S. Company plans to expand indications to general and gynecologic surgery.
1mo ago
4Sep
Medtronic executives to speak at Wells Fargo and Morgan Stanley conferences
CEO Geoff Martha and CFO Thierry Piéton to speak at Wells Fargo Healthcare Conference on Sept. 8, 2026. CFO Piéton to address Morgan Stanley Global Healthcare Conference on Sept. 15, 2026. Live webcasts and archives available via Medtronic's investor relations site.
1mo ago
2Sep
Medtronic Q1 EPS beats at $1.45; analysts raise price targets
Medtronic Q1 FY27 EPS of $1.45 beat estimates of $1.39 by 4.32%. Revenue reached $9.756 billion, exceeding consensus of $9.545 billion. Fiscal 2027 organic revenue guidance raised to 7.25%-7.75%. Company invested $700 million in Cornerstone Robotics partnership.
1mo ago
1Sep
Medtronic Q2 Adj EPS guidance of $1.32-$1.34 meets estimates
Medtronic guides Q2 adjusted EPS to $1.32-$1.34. Upper end of guidance range matches $1.34 analyst estimate. No revenue or net profit figures disclosed in source.
